Antitumor activity of lenvatinib against acquired resistance tumor to anti-VEGF therapy in mouse syngeneic tumor models

被引：0
|
作者：
Ichikawa, Kenji [1 ]
Miyano, Saori Watanabe [1 ]
Minoshima, Yukinori [1 ]
Matsui, Junji [1 ]
Funahashi, Yasuhiro [1 ]
机构：
[1] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki, Japan
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-196
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
196
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ANTITUMOR EFFECT OF THE YEAST POLYSACCHARIDE PREPARATION IN SYNGENEIC MOUSE-TUMOR MODELS
    KUMANO, N
    SUZUKI, S
    ISHIKAWA, T
    KOINUMARU, S
    KONNO, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 146 (01): : 89 - 96
  • [22] Novel fluorinated polycationic delivery of anti-VEGF siRNA for tumor therapy
    Zihan Yuan
    Xiaoshuang Guo
    Minyan Wei
    Yang Xu
    Zhiwei Fang
    Yun Feng
    Wei-En Yuan
    NPG Asia Materials, 2020, 12
  • [23] Acquired resistance to anti-VEGF therapy in glioblastoma is associated with an inflammatory and mesenchymal phenotype
    Piao, Yuji
    Liang, Ji
    Holmes, Lindsay
    Henry, Verlene
    de Groot, John F.
    CANCER RESEARCH, 2012, 72
  • [24] Novel fluorinated polycationic delivery of anti-VEGF siRNA for tumor therapy
    Yuan, Zihan
    Guo, Xiaoshuang
    Wei, Minyan
    Xu, Yang
    Fang, Zhiwei
    Feng, Yun
    Yuan, Wei-En
    NPG ASIA MATERIALS, 2020, 12 (01)
  • [25] Resistance of a VEGF-producing tumor to anti-VEGF antibody: Unimpeded growth of human rhabdoid tumor xenografts - Discussion
    Skinner, M
    Soffer, SZ
    JOURNAL OF PEDIATRIC SURGERY, 2002, 37 (03) : 531 - 532
  • [26] Anti-tumor Activities of Lenvatinib Against RET Gene Fusion Driven Tumor Models
    Okamoto, K.
    Kodama, K.
    Takase, K.
    Nakamoto, K.
    Coffey, H.
    Selvaraj, A.
    Smith, P. G.
    Iwata, M.
    Tsuruoka, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 94 - 94
  • [27] Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models
    Franklin, M.
    Thayer, M.
    Draper, D.
    Saims, D.
    Wise, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S97 - S97
  • [28] Antitumor activity of the oncolytic peptide LTX-315 in syngeneic tumor models
    Camilio, Ketil Andre
    Sveinbjornsson, Baldur
    Maubant, Sylvie
    Serin, Guillaume
    Mirjolet, Jean-Francois
    Bichat, Francis
    Rekdal, Oystein
    CANCER RESEARCH, 2016, 76
  • [29] Evaluation of antitumor activity of lenvatinib plus anti-PD-1 antibody combination in the hepatocellular carcinoma Hepa1-6 mouse syngeneic tumor model
    Kimura, T.
    Kato, Y.
    Ozawa, Y.
    Kodama, K.
    Ito, J.
    Ichikawa, K.
    Yamada, K.
    Hori, Y.
    Tabata, K.
    Takase, K.
    Matsui, J.
    Funahashi, Y.
    Nomoto, K.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E126 - E127
  • [30] RNA aptamers with anti-VEGF, anti-angiogenic and anti-prostate tumor activity
    Zhang, S
    Cheng, L
    Xu, W
    Dominguez, J
    LABORATORY INVESTIGATION, 2002, 82 (01) : 188A - 188A
12345